Targeted Therapies for Lung Cancer
This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growin...
| Other Authors: | Salgia, Ravi., SpringerLink (Online service) |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cham :
Springer,
2019.
Cham : 2019. |
| Physical Description: |
1 online resource (244 pages). |
| Series: |
Current cancer research.
|
| Subjects: |
| LEADER | 04407cam a2200769 a 4500 | ||
|---|---|---|---|
| 001 | 1108535940 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr un|---aucuu | ||
| 008 | 190720s2019 sz ob 001 0 eng d | ||
| 015 | |a GBB9E4469 |2 bnb | ||
| 016 | 7 | |a 019449049 |2 Uk | |
| 019 | |a 1106162127 |a 1107346481 |a 1117502897 | ||
| 020 | |a 9783030178321 |q (electronic bk.) | ||
| 020 | |a 3030178323 |q (electronic bk.) | ||
| 020 | |z 9783030178314 |q (print) | ||
| 020 | |z 3030178315 | ||
| 024 | 8 | |a 10.1007/978-3-030-17 | |
| 035 | |a (OCoLC)1108535940 |z (OCoLC)1106162127 |z (OCoLC)1107346481 |z (OCoLC)1117502897 | ||
| 037 | |a com.springer.onix.9783030178321 |b Springer Nature | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d GW5XE |d LQU |d DCT |d YDX |d OCLCF |d OCLCQ |d DKU |d UKMGB |d OCLCQ |d UKAHL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 049 | |a COM6 | ||
| 050 | 4 | |a RC280.L8 | |
| 082 | 0 | 4 | |a 616.99/42406 |2 23 |
| 245 | 0 | 0 | |a Targeted Therapies for Lung Cancer / |c Ravi Salgia, editor. |
| 260 | |a Cham : |b Springer, |c 2019. | ||
| 264 | 1 | |a Cham : |b Springer, |c 2019. | |
| 300 | |a 1 online resource (244 pages). | ||
| 336 | |a text |b txt |2 rdacontent. | ||
| 337 | |a computer |b c |2 rdamedia. | ||
| 338 | |a online resource |b cr |2 rdacarrier. | ||
| 490 | 1 | |a Current Cancer Research Ser. | |
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a 1. EGFR -- 2. ALK -- 3. ROS1 -- 4. B-RAF -- 5. MET -- 6. HER2 -- 7. NTRK -- 8. SCLC -- 9. Complexities of the Lung Tumor Microenvironment -- 10. KRAS -- 11. Targeting Epigenetic Regulators in Cancer to Overcome Targeted Therapy Resistance. | |
| 520 | |a This book contextualizes translational research and provides an up to date progress report on therapies that are currently being targeted in lung cancer. It is now well established that there is tremendous heterogeneity among cancer cells both at the inter- and intra-tumoral level. Further, a growing body of work highlights the importance of targeted therapies and personalized medicine in treating cancer patients. In contrast to conventional therapies that are typically administered to the average patient regardless of the patients genotype, targeted therapies are tailored to patients with specific traits. Nonetheless, such genetic changes can be disease-specific and/or target specific; thus, the book addresses these issues manifested in the somatically acquired genetic changes of the targeted gene. Each chapter is written by a leading medical oncologist who specializes in thoracic oncology and is devoted to a particular target in a specific indication. Contributors provide an in-depth review of the literature covering the mechanisms underlying signaling, potential cross talk between the target and downstream signaling, and potential emergence of drug resistance. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 650 | 0 | |a Lungs |x Cancer |x Treatment. | |
| 650 | 0 | |a Drug targeting. | |
| 650 | 2 | |a Drug Delivery Systems. | |
| 650 | 6 | |a Poumons |x Cancer |x Traitement. | |
| 650 | 6 | |a Médicaments |x Ciblage. | |
| 650 | 7 | |a Drug targeting. |2 fast. | |
| 650 | 7 | |a Lungs |x Cancer |x Treatment. |2 fast. | |
| 700 | 1 | |a Salgia, Ravi. | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 776 | 0 | 8 | |i Print version: |a Salgia, Ravi. |t Targeted Therapies for Lung Cancer. |d Cham : Springer, ©2019 |z 9783030178314. |
| 830 | 0 | |a Current cancer research. | |
| 907 | |a .b5983285x |b multi |c - |d 190902 |e 240516 | ||
| 998 | |a (3)cue |a cu |b 240404 |c m |d z |e - |f eng |g sz |h 0 |i 2 | ||
| 948 | |a MARCIVE Overnight, in 2024.04 | ||
| 948 | |a MARCIVE Overnight, in 2023.02 | ||
| 948 | |a MARCIVE Over, 07/2021 | ||
| 948 | |a MARCIVE Comp, 06/2020 | ||
| 948 | |a MARCIVE Overnight 09/2019 | ||
| 994 | |a 92 |b COM | ||
| 995 | |a Loaded with m2btab.ltiac in 2024.04 | ||
| 995 | |a Loaded with m2btab.elec in 2024.04 | ||
| 995 | |a Loaded with m2btab.ltiac in 2023.02 | ||
| 995 | |a Loaded with m2btab.ltiac in 2021.07 | ||
| 995 | |a Loaded with m2btab.elec in 2021.06 | ||
| 995 | |a Loaded with m2btab.ltiac in 2020.06 | ||
| 995 | |a Loaded with m2btab.ltiac in 2019.10 | ||
| 995 | |a Loaded with m2btab.elec in 2019.09 | ||
| 999 | |e z | ||
| 999 | |a cue | ||
| 989 | |d cueme |e - - |f - - |g - |h 0 |i 0 |j 200 |k 240404 |l $0.00 |m |n - - |o - |p 0 |q 0 |t 0 |x 0 |w SpringerLink |1 .i151525225 |u http://ezproxy.coloradomesa.edu/login?url=https://link.springer.com/10.1007/978-3-030-17832-1 |3 SpringerLink |z Click here for access | ||